Lilly Sells Keflex Antibiotic To Advancis; Plans For Once-Daily Dosing Underway
This article was originally published in The Pink Sheet Daily
Executive Summary
Advancis will commence clinical trials with Keflex using proprietary Pulsys drug delivery technology. The company also has Pulsys agreements with GSK for Augmentin and with Par for amoxicillin.